Oscar Gruss Upgrades RADVision Ltd. (RVSN) to Hold; Shares Currently Trade at Cash Levels
RVSN Hot Sheet
Rating Summary:1 Buy, 1 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 16 | Down: 7 | New: 23
Oscar Gruss upgrades RADVision Ltd. (Nasdaq: RVSN) from Reduce to Hold. Price target $6.
Oscar analyst says, "RVSN better-than-expected earnings remain overshadowed by concerns over the future with Cisco (Nasdaq: CSCO). With RVSN market in the eye of the storm, we continue to monitor closely forthcoming reflections on RVSN. Considering the company’s stock currently trades at cash levels, we are upgrading to HOLD and maintaining $6.00 Price Target...Expecting the worst, management scaled-down OpEx once more, however we expect more downsizing measures down the road. We model $21.5M/$0.17 for 4Q09 and $79.8M/$0.40 for 2009."
To see more analyst ratings on RVSN Click Here.
RADVISION Ltd. engages in the design, development, and supply of products and technologies for videoconferencing and video telephony, as well as for converged voice, video, and data over Internet Protocol (IP) and 3G networks.
Oscar analyst says, "RVSN better-than-expected earnings remain overshadowed by concerns over the future with Cisco (Nasdaq: CSCO). With RVSN market in the eye of the storm, we continue to monitor closely forthcoming reflections on RVSN. Considering the company’s stock currently trades at cash levels, we are upgrading to HOLD and maintaining $6.00 Price Target...Expecting the worst, management scaled-down OpEx once more, however we expect more downsizing measures down the road. We model $21.5M/$0.17 for 4Q09 and $79.8M/$0.40 for 2009."
To see more analyst ratings on RVSN Click Here.
RADVISION Ltd. engages in the design, development, and supply of products and technologies for videoconferencing and video telephony, as well as for converged voice, video, and data over Internet Protocol (IP) and 3G networks.
You May Also Be Interested In
- UPDATE: Williams Financial Group Upgrades Semtech Corp. (SMTC) to Buy; Check Again...Quarter Was Fairly Strong
- UBS Maintains a 'Neutral' on VeriFone (PAY); Europe Demand Healthy, but FX Emerges as Headwind
- Wells Fargo Upgrades Watson Pharmaceuticals (WPI) to Outperform; Actavis Acquisition Adds Growth Prospects
Create E-mail Alert Related Categories
UpgradesRelated Entities
Oscar GrussSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
